Literature DB >> 6608523

Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization.

B B Aggarwal, B Moffat, R N Harkins.   

Abstract

Human lymphotoxin was purified to homogeneity from a serum-free tissue culture supernatant of a lymphoblastoid 1788 cell line. The purification scheme consisted of DEAE-cellulose chromatography, preparative isoelectric focusing, lentil lectin-Sepharose chromatography, and preparative polyacrylamide gel electrophoresis. The purified glycoprotein was homogeneous by the criteria of high pressure liquid chromatography and polyacrylamide gel electrophoresis run under both nondenaturing and denaturing conditions. The specific activity of the purified lymphotoxin is approximately 40 X 10(6) units/mg. The protein has an apparent molecular weight of approximately 20,000, and RF of 0.33 on 7.5% polyacrylamide gels at pH 8.8 and an isoelectric point of 5.8. A tryptic digest of the purified native material produced two major fragments of approximately 15,000 and 5,000 Da. The amino acid compositions of the intact molecule and of the tryptic fragments are presented.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608523

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

Review 1.  Pharmacodynamic monitoring of cyclosporin.

Authors:  W M Awni
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

2.  Haplotypic polymorphisms of the TNFB gene.

Authors:  L J Abraham; D C Du; K Zahedi; R L Dawkins; A S Whitehead
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Impairment of cytokine production in mice fed a vitamin D3-deficient diet.

Authors:  M Kankova; W Luini; M Pedrazzoni; F Riganti; M Sironi; B Bottazzi; A Mantovani; A Vecchi
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

4.  Cytostatic activity of dialyzed SDS-page eluates.

Authors:  K K Ericson; T J Yang
Journal:  In Vitro Cell Dev Biol       Date:  1992-01

5.  Relationship between a novel human cytotoxin (factor 2) produced by a B cell line (Karpas 160) and phorbol-myristate-acetate-associated cytotoxicity.

Authors:  J Ni; A Karpas
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

6.  Low concentrations of TNF-α promote osteogenic differentiation via activation of the ephrinB2-EphB4 signalling pathway.

Authors:  Limei Wang; Jin Zhang; Cunwei Wang; Yuping Qi; Mi Du; Wenhua Liu; Chengzhe Yang; Pishan Yang
Journal:  Cell Prolif       Date:  2016-10-11       Impact factor: 6.831

7.  Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor.

Authors:  D Pennica; J S Hayflick; T S Bringman; M A Palladino; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

Review 8.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 9.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

10.  Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor.

Authors:  K Haranaka; E A Carswell; B D Williamson; J S Prendergast; N Satomi; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.